Literature DB >> 12230967

Anabolic steroid abuse and dependence.

Kirk J Brower1.   

Abstract

Anabolic-androgenic steroids (AAS) are mainly used to treat androgen deficiency syndromes and, more recently, catabolic states such as AIDS-associated wasting. There is no evidence in the reviewed literature that AAS abuse or dependence develops from the therapeutic use of AAS. Conversely, 165 instances of AAS dependence have been reported among weightlifters and bodybuilders who, as part of their weight training regimens, chronically administered supraphysiologic doses, often including combinations of injected and oral AAS as well as other drugs of abuse. A new model is proposed in which both the "myoactive" and psychoactive effects of AAS contribute to the development of AAS dependence. The adverse consequences of AAS are reviewed, as well as their assessment by means of a history and physical, mental status examination, and laboratory testing. When patients with AAS use disorders are compared with patients with other substance use disorders, both similarities and differences become apparent and have implications for treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12230967     DOI: 10.1007/s11920-002-0086-6

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  70 in total

1.  Anabolic steroid dependence.

Authors:  L R Hays; S Littleton; V Stillner
Journal:  Am J Psychiatry       Date:  1990-01       Impact factor: 18.112

2.  Anabolic-androgenic steroid dependence in a woman.

Authors:  J Copeland; R Peters; P Dillon
Journal:  Aust N Z J Psychiatry       Date:  1998-08       Impact factor: 5.744

3.  Anabolic-androgenic steroid dependence.

Authors:  K J Brower; F C Blow; T P Beresford; C Fuelling
Journal:  J Clin Psychiatry       Date:  1989-01       Impact factor: 4.384

4.  Evaluation of aminotransferase elevations in a bodybuilder using anabolic steroids: hepatitis or rhabdomyolysis?

Authors:  R Pertusi; R D Dickerman; W J McConathy
Journal:  J Am Osteopath Assoc       Date:  2001-07

5.  Anabolic steroid dependence with opioid-type features.

Authors:  F Tennant; D L Black; R O Voy
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

6.  The effects of nandrolone decanoate on cocaine-induced kindling in male rats.

Authors:  S F Long; M C Wilson; W M Davis
Journal:  Neuropharmacology       Date:  2000-09       Impact factor: 5.250

7.  Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial.

Authors:  H G Pope; E M Kouri; J I Hudson
Journal:  Arch Gen Psychiatry       Date:  2000-02

8.  Ergogenic supplements and health risk behaviors.

Authors:  M B Stephens; C Olsen
Journal:  J Fam Pract       Date:  2001-08       Impact factor: 0.493

9.  Abuse liability of testosterone.

Authors:  M I Fingerhood; J T Sullivan; M Testa; D R Jasinski
Journal:  J Psychopharmacol       Date:  1997       Impact factor: 4.153

10.  A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.

Authors:  Katharine A Phillips; Ralph S Albertini; Steven A Rasmussen
Journal:  Arch Gen Psychiatry       Date:  2002-04
View more
  40 in total

1.  Trends in non-medical use of anabolic steroids by U.S. college students: results from four national surveys.

Authors:  Sean Esteban McCabe; Kirk J Brower; Brady T West; Toben F Nelson; Henry Wechsler
Journal:  Drug Alcohol Depend       Date:  2007-05-23       Impact factor: 4.492

Review 2.  Adolescents and androgens, receptors and rewards.

Authors:  Satoru M Sato; Kalynn M Schulz; Cheryl L Sisk; Ruth I Wood
Journal:  Horm Behav       Date:  2008-02-13       Impact factor: 3.587

Review 3.  Neuropsychiatric effects of prescription drug abuse.

Authors:  Jason P Caplan; Lucy A Epstein; Davin K Quinn; Jonathan R Stevens; Theodore A Stern
Journal:  Neuropsychol Rev       Date:  2007-08-16       Impact factor: 7.444

4.  Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2009-04-01       Impact factor: 4.492

5.  Region-specific mechanisms for testosterone-induced Fos in hamster brain.

Authors:  Anita Nagypál; Ruth I Wood
Journal:  Brain Res       Date:  2007-01-12       Impact factor: 3.252

Review 6.  Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern?

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2008-07-02       Impact factor: 4.492

7.  Adolescent anabolic/androgenic steroids: Aggression and anxiety during exposure predict behavioral responding during withdrawal in Syrian hamsters (Mesocricetus auratus).

Authors:  Lesley A Ricci; Thomas R Morrison; Richard H Melloni
Journal:  Horm Behav       Date:  2013-10-11       Impact factor: 3.587

Review 8.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

9.  Clinical features of muscle dysmorphia among males with body dysmorphic disorder.

Authors:  Courtney G Pope; Harrison G Pope; William Menard; Christina Fay; Roberto Olivardia; Katharine A Phillips
Journal:  Body Image       Date:  2005-12

10.  Testosterone reinforcement: intravenous and intracerebroventricular self-administration in male rats and hamsters.

Authors:  Ruth I Wood; Luke R Johnson; Lucy Chu; Christina Schad; David W Self
Journal:  Psychopharmacology (Berl)       Date:  2003-10-14       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.